Preprocedural arterial lactate is associated with atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation

The heart is a muscle that relies on a steady supply of energy to keep its rhythm, much like any other engine requires fuel to run smoothly. When this rhythm goes wrong, a condition called atrial fibrillation occurs, where the upper chambers of the heart beat chaotically instead of in a coordinated pulse. This irregularity can lead to serious complications, including stroke and heart failure. For many patients, doctors use a procedure called catheter ablation to fix the problem. In this treatment, a thin tube is threaded through a vein to the heart, where it uses heat to create tiny scars on the heart tissue. These scars block the erratic electrical signals that cause the chaotic beating, aiming to restore a normal rhythm. While this procedure is often successful, it does not work for everyone, especially in cases where the irregular rhythm has been present for a long time. Scientists have long searched for simple clues that could predict which patients are most likely to see their condition return after the procedure, hoping to find markers that are easy to measure before the surgery even begins.

Researchers at Beijing Anzhen Hospital recently looked into a specific, routine blood test that is often taken before medical procedures: the measurement of lactate in the arteries. Lactate is a substance produced by the body when cells break down sugar for energy, and it is commonly checked to see if a patient is under severe stress or if their body is not getting enough oxygen. However, in patients who are stable and preparing for an elective heart procedure, the levels of this substance are usually within a normal range. The team wanted to know if even small differences in these normal levels could tell them something important about the future success of the ablation. They focused on patients with persistent atrial fibrillation, a form of the condition that lasts for more than a week and is harder to treat than shorter episodes. By reviewing the medical records of hundreds of patients who had undergone this surgery, the researchers hoped to uncover a hidden link between the body's metabolic state before the operation and the likelihood of the heart rhythm returning to normal afterward.

The study involved a careful review of 203 patients who had received their first radiofrequency catheter ablation for persistent atrial fibrillation between 2018 and 2023. Before the procedure, each patient had an arterial blood gas test, which measures the levels of oxygen, carbon dioxide, and other chemicals in the blood drawn from an artery. The researchers specifically tracked the amount of lactate in these samples. Over an average follow-up period of nearly four years, the team monitored the patients to see if their heart rhythm returned to a chaotic state. The results revealed a surprising pattern: patients whose hearts returned to an irregular rhythm had lower levels of lactate before the surgery compared to those whose hearts stayed in a normal rhythm. Specifically, the average lactate level in the group that experienced a recurrence was 1.6 millimoles per liter, while the group that remained free of the condition had an average level of 1.9 millimoles per liter.

When the researchers analyzed the data statistically, they found that for every increase of one millimole per liter in the lactate level, the risk of the heart rhythm returning dropped significantly. This relationship held true even after the team accounted for other factors that could influence the outcome, such as the patient's age, sex, body mass, and history of high blood pressure or diabetes. To make the finding easier to visualize, the researchers also divided the patients into two groups based on a specific threshold of 1.9 millimoles per liter. Those with levels at or above this number were less likely to see their condition return than those with levels below it. The data suggested that patients with the higher lactate levels had a roughly 40 percent lower chance of recurrence compared to those with lower levels. This was a consistent finding whether the lactate was looked at as a continuous number or split into these two categories.

Despite the clear statistical link, the authors are careful to explain that this does not mean low lactate causes the heart rhythm to return, nor does it mean that raising lactate would fix the problem. The study was retrospective, meaning it looked back at past records rather than testing a new treatment, so it cannot prove cause and effect. The researchers also noted that their group of patients was almost entirely male, which means the findings might not apply equally to women. Furthermore, the specific cutoff point of 1.9 millimoles per liter was chosen by looking at the data from this specific group of patients, so it has not been tested in a different set of people to see if it holds up. The team suggests that this result is a hypothesis-generating observation, a clue that warrants further investigation rather than a rule to be applied immediately in clinical practice.

The discovery challenges a common assumption in medicine. In critically ill patients, high levels of lactate are usually a bad sign, indicating that the body is struggling to get enough oxygen or that the organs are failing. In those emergency situations, a high reading is a warning bell. In this study of stable patients, however, the opposite appeared to be true: a slightly higher level of lactate within the normal range seemed to be associated with a better outcome. The researchers speculate that this might be because lactate is not just a waste product but also a fuel source and a signaling molecule that helps cells communicate. It is possible that the body's ability to produce or utilize lactate reflects a deeper metabolic health that supports the heart's ability to maintain a steady rhythm after the electrical reset of ablation.

Ultimately, this paper adds a new piece to the puzzle of understanding why some heart procedures work better than others. It suggests that a simple, routine blood test taken before surgery might contain more information than doctors currently realize. While the findings are intriguing, the authors emphasize that more research is needed in larger and more diverse groups of people before this test can be used to guide treatment decisions. For now, the study stands as a reminder that the body's metabolic signals, even when they appear normal, may hold subtle keys to predicting the future health of the heart. The work invites scientists to look closer at the chemistry of stable patients, searching for the quiet signals that might one day help ensure that a restored heart rhythm stays restored.